Follow
Nishat Manzar
Nishat Manzar
Dana-Farber Cancer Institute
Verified email at dfci.harvard.edu
Title
Cited by
Cited by
Year
Androgen deprivation upregulates SPINK1 expression and potentiates cellular plasticity in prostate cancer
R Tiwari, N Manzar, V Bhatia, A Yadav, MA Nengroo, D Datta, ...
Nature Communications 11 (1), 384, 2020
652020
Dynamics of cellular plasticity in prostate cancer progression
R Tiwari, N Manzar, B Ateeq
Frontiers in Molecular Biosciences 7, 130, 2020
242020
Proproliferative function of adaptor protein GRB10 in prostate carcinoma
MI Khan, A Al Johani, A Hamid, B Ateeq, N Manzar, VM Adhami, RK Lall, ...
The FASEB Journal 33 (3), 3198, 2019
132019
Transcription networks rewire gene repertoire to coordinate cellular reprograming in prostate cancer
N Manzar, P Ganguly, UK Khan, B Ateeq
Seminars in Cancer Biology 89, 76-91, 2023
82023
Computational Design of BH3-Mimetic Peptide Inhibitors That Can Bind Specifically to Mcl-1 or Bcl-XL: Role of Non-Hot Spot Residues
CN Reddy, N Manzar, B Ateeq, R Sankararamakrishnan
Biochemistry 59 (45), 4379-4394, 2020
82020
A Drosophila model of oral peptide therapeutics for adult intestinal stem cell tumors
A Bajpai, TA Quazi, HW Tang, N Manzar, V Singh, A Thakur, B Ateeq, ...
Disease models & mechanisms 13 (7), dmm044420, 2020
62020
Entropically driven controlled release of paclitaxel from poly (2-ethyl-2-oxazoline) coated maghemite nanostructures for magnetically guided cancer therapy
N Kumar, S Tyeb, N Manzar, L Behera, B Ateeq, V Verma
Soft Matter 14 (31), 6537-6553, 2018
62018
Implications of the circular RNAs in localized prostate cancer
S Nigam, N Manzar, B Ateeq
Annals of Translational Medicine 7 (Suppl 6), 2019
32019
An integrative proteomics approach identifies tyrosine kinase KIT as a therapeutic target for SPINK1-positive prostate cancer
N Manzar, UK Khan, A Goel, S Carskadon, N Gupta, N Palanisamy, ...
Iscience 27 (3), 2024
12024
A Computational Pipeline to Design BH3-Mimetic Peptide Inhibitors that Can Bind Specifically to Mcl-1 Or Bcl-XL: Role of Non-Hotspot Residues
N Reddy, N Manzar, B Ateeq, R Sankararamakrishnan
Biophysical Journal 120 (3), 177a-178a, 2021
12021
Androgen deprivation upregulates SPINK1 expression and potentiates cellular plasticity in prostate cancer
R Tiwari, N Manzar, V Bhatia, A Yadav, S Carskadon, N Gupta, ...
bioRxiv, 562652, 2019
12019
Erratum to: Proproliferative function of adaptor protein GRB10 in prostate carcinoma (vol 37, e22754, 2023)
M Khan, A Al Johani, A Hamid, B Ateeq, N Manzar, VF Adhami, RK Lall, ...
FASEB JOURNAL 37 (4), 2023
2023
Human ERG oncoprotein represses a Drosophila LIM domain binding protein–coding gene Chip
M Bharti, A Bajpai, U Rautela, N Manzar, B Ateeq, P Sinha
Proceedings of the National Academy of Sciences 120 (2), e2211189119, 2023
2023
An integrative proteomics approach identifies tyrosine kinase KIT as a novel therapeutic target for SPINK1-positive prostate cancer.
N Manzar, UK Khan, A Goel, S Carskadon, N Gupta, N Palanisamy, ...
bioRxiv, 2023.07. 24.550265, 2023
2023
Human ERG Oncoprotein Represses Chip/LDB1 LIM-Domain Binding Gene in Drosophila
M Bharti, A Bajpai, U Rautela, N Manzar, B Ateeq, P Sinha
bioRxiv, 2022.06. 05.494862, 2022
2022
A novel computational method to design BH3-mimetic peptide inhibitors that can bind specifically to Mcl-1 or Bcl-XL
CN Reddy, N Manzar, B Ateeq, R Sankararamakrishnan
bioRxiv, 2020.07. 09.194662, 2020
2020
Reprogramming transcription factors SOX2 and REST modulates SPINK1 expression in governing cellular plasticity in prostate cancer
N Manzar, R Tiwari, V Bhatia, A Yadav, S Carskadon, N Gupta, ...
MOLECULAR CANCER THERAPEUTICS 18 (12), 2019
2019
Abstract C128: Reprogramming transcription factors SOX2 and REST modulates SPINK1 expression in governing cellular plasticity in prostate cancer
N Manzar, R Tiwari, V Bhatia, A Yadav, S Carskadon, N Gupta, ...
Molecular Cancer Therapeutics 18 (12_Supplement), C128-C128, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–18